These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 11098193
1. Results of the 1997 SENTRY Antimicrobial Surveillance Program in Three Brazilian Medical Centers. Sader HS, Sampaio JL, Zoccoli C, Jones RN. Braz J Infect Dis; 1999 Apr; 3(2):63-79. PubMed ID: 11098193 [Abstract] [Full Text] [Related]
2. Global view of antimicrobial resistance. Findings of the SENTRY Antimicrobial Surveillance Program, 1997-1999. Pfaller MA, Jones RN. Postgrad Med; 2001 Feb; 109(2 Suppl):10-21. PubMed ID: 19667553 [Abstract] [Full Text] [Related]
3. In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program. Jones RN, Pfaller MA. Clin Infect Dis; 2000 Aug; 31 Suppl 2():S16-23. PubMed ID: 10984323 [Abstract] [Full Text] [Related]
4. Assessment of pathogen frequency and resistance patterns among pediatric patient isolates: report from the 2004 SENTRY Antimicrobial Surveillance Program on 3 continents. Fedler KA, Biedenbach DJ, Jones RN. Diagn Microbiol Infect Dis; 2006 Dec; 56(4):427-36. PubMed ID: 16938419 [Abstract] [Full Text] [Related]
5. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia. Fritsche TR, Sader HS, Stilwell MG, Dowzicky MJ, Jones RN. Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563 [Abstract] [Full Text] [Related]
6. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004). Watters AA, Jones RN, Leeds JA, Denys G, Sader HS, Fritsche TR. J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511 [Abstract] [Full Text] [Related]
7. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). Biedenbach DJ, Moet GJ, Jones RN. Diagn Microbiol Infect Dis; 2004 Sep; 50(1):59-69. PubMed ID: 15380279 [Abstract] [Full Text] [Related]
8. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit. Sader HS, Jones RN, Dowzicky MJ, Fritsche TR. Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565 [Abstract] [Full Text] [Related]
9. Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003). Sader HS, Fritsche TR, Jones RN. Diagn Microbiol Infect Dis; 2005 Jul; 52(3):265-73. PubMed ID: 16105569 [Abstract] [Full Text] [Related]
10. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Jones RN, Sader HS, Fritsche TR, Pottumarthy S. Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923 [Abstract] [Full Text] [Related]
12. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program. Sader HS, Castanheira M, Mendes RE, Toleman M, Walsh TR, Jones RN. Int J Antimicrob Agents; 2005 Jan; 25(1):57-61. PubMed ID: 15620827 [Abstract] [Full Text] [Related]
16. Bacterial Pathogens Isolated from Patients with Bloodstream Infections in Latin America, 1997: Frequency of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program. Sader HS, Pfaller MA, Jones RN, Doern GV, Gales AC, Winokur PL, Kugler KC. Braz J Infect Dis; 1999 Jun; 3(3):97-110. PubMed ID: 11097713 [Abstract] [Full Text] [Related]
17. Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program. Tognim MC, Andrade SS, Silbert S, Gales AC, Jones RN, Sader HS. Int J Infect Dis; 2004 Sep; 8(5):284-91. PubMed ID: 15325597 [Abstract] [Full Text] [Related]
18. Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004). Fritsche TR, Sader HS, Jones RN. Diagn Microbiol Infect Dis; 2007 May; 58(1):19-26. PubMed ID: 17383139 [Abstract] [Full Text] [Related]
19. Frequency of isolation and antimicrobial susceptibility of bacteria isolated from bloodstream infections at Children's Medical Center, Tehran, Iran, 1996-2000. Mamishi S, Pourakbari B, Ashtiani MH, Hashemi FB. Int J Antimicrob Agents; 2005 Nov; 26(5):373-9. PubMed ID: 16213124 [Abstract] [Full Text] [Related]
20. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae. Jones RN, Sader HS, Stilwell MG, Fritsche TR. Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904 [Abstract] [Full Text] [Related] Page: [Next] [New Search]